XML 47 R35.htm IDEA: XBRL DOCUMENT v3.24.3
Basis of Presentation and Use of Estimates Organization, Consolidation and Presentation of Financial Statements (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Aug. 20, 2024
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Line Items]                      
Net sales   $ 649,729 $ 632,124 $ 1,899,025 $ 1,990,078            
Cost of goods sold   293,826 296,441 862,037 929,495            
Deferred Revenue   64,000   64,000       $ 68,300      
Retained earnings   8,132,231   8,132,231       9,260,629      
Accumulated other comprehensive loss   (315,274)   (315,274)       (336,038)      
Total stockholders' equity   $ 7,487,859 8,416,198 $ 7,487,859 8,416,198 $ 6,778,787 $ 9,051,134 8,741,133 $ 8,446,893 $ 9,763,716 $ 9,615,252
Revenue Allocation Percent To Lease Elements   3.00%   3.00%              
Additional paid-in-capital   $ 448,329   $ 448,329       449,075      
Selling, general and administrative expense   200,440 201,199 610,042 634,576            
Interest expense   12,174 12,398 36,715 37,078            
Other Nonoperating Income (Expense)   18,081 20,446 70,740 87,365            
Deferred Revenue, Current   48,900   48,900       $ 51,100      
Saber Bio Acquisition | Research and Development Expense                      
Organization, Consolidation and Presentation of Financial Statements [Line Items]                      
Asset Acquisition, Consideration Transferred $ 29,500                    
Europe [Member]                      
Organization, Consolidation and Presentation of Financial Statements [Line Items]                      
Net sales   205,700 193,100 612,400 609,100            
Asia Pacific [Member]                      
Organization, Consolidation and Presentation of Financial Statements [Line Items]                      
Net sales   126,900 118,900 375,200 398,900            
UNITED STATES                      
Organization, Consolidation and Presentation of Financial Statements [Line Items]                      
Net sales   276,200 275,400 783,400 858,800            
Americas [Member]                      
Organization, Consolidation and Presentation of Financial Statements [Line Items]                      
Net sales   $ 40,900 $ 44,700 $ 128,000 $ 123,300